{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:35:46Z","timestamp":1725842146133},"reference-count":16,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,7,7]],"date-time":"2009-07-07T00:00:00Z","timestamp":1246924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background and aims: <\/jats:bold> Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) demonstrate an affinity towards lymphocytes B, stimulating the production of cryoglobulins. Deposits of cryoprecipitates contribute to glomerulonephritis and renal failure. The presence of cryoglobulins was investigated in the sera of HCV\u2010monoinfected and HCV\/HIV\u2010coinfected individuals. Associations between types of cryoglobulins and HCV genotypes, viral load and renal function tests were also evaluated.<\/jats:p><jats:p><jats:bold>Patients and methods: <\/jats:bold> Seventy\u2010seven patients were enrolled in this study. Forty\u2010four were HCV infected and 33 were HCV\/HIV coinfected. Cryoglobulins were detected in the sera by electrophoresis and immunofixation. Serum urea and creatinine concentration, glomerular filtration rate (GFR) and serum cystatin C concentration (CC) were analysed to evaluate renal function. The control group included 16 healthy individuals.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> The occurrence of cryoglobulinaemia in HCV\u2010monoinfected patients was 55%, whereas in HCV\/HIV\u2010coinfected patients it was 64%. Mixed cryoglobulinaemia type II was determined in 34%, whereas type III in 25%. The prevalence of cryoglobulinaemia was significantly higher in infection with HCV genotype 1 vs. genotype 3 (65 vs. 50%; <jats:italic>P<\/jats:italic>&lt;0.01). The most frequently occurring heavy chains were \u03b3\u2010type (96%). Light chains, the \u03ba\u2010type, were detected in all patients. The CC concentration was significantly higher in HCV\/HIV\u2010coinfected patients compared with controls (718 vs. 392\u2003ng\/ml; <jats:italic>P<\/jats:italic>&lt;0.005) or HCV\u2010monoinfected patients (508\u2003ng\/ml; <jats:italic>P<\/jats:italic>&lt;0.007). There was correlation between the serum CC concentration and the incidence of cryoglobulinaemia (<jats:italic>R<\/jats:italic>=0.44; <jats:italic>P<\/jats:italic>&lt;0.00015), which was particularly evident in HCV monoinfection (<jats:italic>R<\/jats:italic>=0.43; <jats:italic>P<\/jats:italic>&lt;0.0034).<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> Genotype\u20101 infection is an important risk factor for cryoglobulinaemia. Standard renal function tests are not sufficient for the prediction of renal failure in HCV\u2010infected patients. Serum CC concentration allows to establish an early diagnosis of renal insufficiency related to cryoglobulinaemia.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2009.02052.x","type":"journal-article","created":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T02:33:48Z","timestamp":1247020428000},"page":"1158-1161","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of cryoglobulinaemia in hepatitis C virus\u2010 and hepatitis C virus\/human immunodeficiency virus\u2010infected individuals: implications for renal function"],"prefix":"10.1111","volume":"29","author":[{"given":"Tadeusz Wojciech","family":"Lapinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Parfieniuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Rogalska\u2010Plonska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Czajkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Flisiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,3]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90132-5"},{"key":"e_1_2_5_3_2","first-page":"6518","article-title":"Chronic hepatitis C virus infection","volume":"13","author":"Stefanova\u2010Petrova DV","year":"2007","journal-title":"prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2004.06.003"},{"key":"e_1_2_5_5_2","first-page":"372","article-title":"Classification of chronic viral hepatitis","volume":"13","author":"Scheuer PJ.","year":"1991","journal-title":"a need for reassessment"},{"key":"e_1_2_5_6_2","first-page":"91","volume-title":"Serum Protein, Electrophoresis, Immunofixation","author":"Le Carrer D.","year":"2005"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2006.07.005"},{"key":"e_1_2_5_8_2","first-page":"1275","article-title":"Hepatitis C virus\u2010associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment","volume":"16","author":"Schott P","year":"2001","journal-title":"Histol Histopathol"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00108-007-2014-7"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01603.x"},{"key":"e_1_2_5_11_2","first-page":"216","article-title":"Efficacy of alpha interferon treatment in patients with chronic hepatitis C associated to mixed cryoglobulinaemia","volume":"8","author":"Scotto G","year":"2000","journal-title":"Infez Med"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2007.10.416"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21190"},{"key":"e_1_2_5_14_2","first-page":"705","article-title":"Early detection of acute renal failure by serum cystatin C","volume":"11","author":"Mazur MJ","year":"2005","journal-title":"a new opportunity for a hepatologist"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350601100502"},{"key":"e_1_2_5_16_2","first-page":"2213","article-title":"Cystatin C level as a marker of kidney function in human immunodeficiency virus infection","volume":"20","author":"Odden MC","year":"2007","journal-title":"the FRAM study"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.051870"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.02052.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2009.02052.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T19:48:36Z","timestamp":1695930516000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.02052.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,3]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1478-3231.2009.02052.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02052.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,3]]}}}